The combination of AFP and sST2 significantly enhanced diagnostic performance, with AUCs of 0.963 for distinguishing HCC from healthy controls and 0.896 for distinguishing HCC from chronic hepatitis B. Studies have shown that combinations of biomarkers provide a higher diagnostic value than single biomarkers (Williams, 2009). Here, AFP is linked to hepatocellular carcinoma.